Apotex Corp. Launches Brimonidine Tartrate Ophthalmic Solution, 0.1% in the United States

Apotex Corp. has released its latest ophthalmic product in the United States, announcing today that brimonidine tartrate ophthalmic solution, 0.1% is now available. Brimonidine is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients…